We think the stake in wide-moat Sartorius contributes to Bio-Rad’s moat. Although Bio-Rad does not have a controlling stake, Sartorius accounts for approximately 40% of Bio-Rad’s fair value in our ...

Irritable Bowel Syndrome, or IBS, affects a large number of people and can be difficult to manage. It causes ongoing ...

A new study accuses LM Arena, the organization behind the popular AI benchmark Chatbot Arena, of helping some AI companies ...

Six professors from the University of California San Diego have been elected in 2025 to the American Academy of Arts and ...

Many of the chemicals identified in plastic food packaging are not just passive elements; they actively disrupt crucial ...

Traditional biochemical methods of studying human gene mutations are often laborious and costly. Now bioengineers at the ...

“This is a clear and deliberate shift,” Corbett says.

Bio-Rad Laboratories BIO is set to give its latest quarterly earnings report on Thursday, 2025-05-01. Here's what investors ...

The company said that its test could overcome sensitivity issues with ultrasound and serum alpha-fetoprotein assays that are used to monitor at-risk patients.

How the Trump administration’s health cuts could kill thousands of test animals - Hundreds of lab animals in West Virginia ...

The New York Times calls him the “Nerd King of Internet Cooking. You could also call him a bestselling cookbook author, a ...

The threat of the avian flu continues to increase as household cats are experiencing increased levels of infections and ...